Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from biotechnology

Bavarian Nordic monkeypox vaccine wins EU approval

Danish biotechnology company Bavarian Nordic said on Monday the European Commission had given permission for its Imvanex vaccine to be marketed as protection against monkeypox, as recommended last week by the European Medicines Agency (EMA).

Reuters

Genetically modified cowpea clears its first hurdle in Ghana, but there's a long way to go

Genetically modified (GM) cowpea has cleared the first of the three regulatory hurdles in the way of commercialisation in Ghana. If it is commercialised, it will be the first GM crop grown in the country – a major milestone. Biotechnology proponents have been working for decades to integrate GM crops…

The Conversation

Gujarat woos biotech firms in Telangana

Holds roadshow in city on its new Biotechnology Policy

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

Tisco Bank unit touts healthcare, biotech

Tisco Bank's wealth advisory unit suggests moving away from energy stocks to biotechnology and healthcare as several US economic indicators have signalled a higher risk of recession.

Bangkok Post

How Nigeria can turn its huge cashew waste into valuable citric acid

Nigeria – the sixth largest producer of cashew nuts globally – exports more than 80% of its raw cashews primarily to Vietman and India where they are processed into various consumer products such as butter, food and cosmetic ingredients.

The Conversation

All higher educational institutions in Tamil Nadu should follow 69% quota in admissions: Minister K Ponmudy

CHENNAI: All higher educational institutions in the state should follow 69% reservation system in admissions, higher education minister K Ponmudy said on Tuesday following opposition from political parties in the state to reserving seats under economically weaker section (EWS) quota in MSc Biotechnology programme offered at Madurai Kamaraj University.

The Times of India

MorphoSys Stock Skyrockets On Entering Equity Participation and License Agreements With HIBio

MorphoSys AG (NASDAQ:MOR) and Human Immunology Biosciences, Inc. (HIBio), a biotechnology company, have established an equity participation agreement and license agreements to allow HIBio to develop and commercialize MorphoSys’ felzartamab, an anti-CD38 antibody, and MOR210, an anti-C5aR1 antibody. HIBio is a biotechnology company based in South San Francisco that focuses on discovering and…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Donaldson Acquires Early-Stage Biotechnology Company Purilogics

Donaldson Company, Inc. (NYSE:DCI) has acquired Purilogics, LLC, an early-stage biotechnology company, for an initial purchase price of $20 million plus milestone-based earnout payments over the next five years. Founded in 2013 by Jinxiang Zhou and Scott Husson, Purilogics is based in Greenville, South Carolina. Purilogics offers a broad portfolio of purification…

Benzinga

Why This Biotech ETF May Be About to Break Out

There’s a chance shares of the iShares Biotechnology ETF (NASDAQ: IBB) may be about to break out. They are testing a resistance level. If they can get above it, a new uptrend may form.

Benzinga

Bavarian Nordic eyes more monkeypox vaccine orders amid global "wake-up call"

Biotechnology company Bavarian Nordic expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from governments around the world, its management told investors on Tuesday.

Reuters

Scotland's biotech sector set to hit key £1 billion milestone

Scotland’s industrial biotechnology community is exceeding growth expectations and is on track to achieve annual turnover of £1.2bn by 2025,…

The National (Scotland)

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Sana Biotechnology (NASDAQ:SANA) shares moved upwards by 9.1% to $6.1 during Friday's after-market session. The company's market cap stands at $1.1 billion.

Benzinga

Govt.'s progress report reflects resolve to push big development projects

Achievements in public health, pandemic control, IT sector, and biotechnology in focus

The Hindu

PDS Biotechnology Gains On FDA Fast Track Designation For Lead Candidate

The U.S.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Insider UK

Industrial biotechnology centre reopens innovation fund to new proposals

While any area of biotech will be considered for funding, it is particularly looking for projects focused on agriculture and food

Benzinga

PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst

Biotechnology is one sector that peaked ahead of the S&P 500 index. While the S&P 500 index did not peak until January, the SPDR Biotech (NYSE: XBI) peaked in February 2021 and is now 60% lower than its all-time high price ($174.79 vs. $66.50).

Benzinga

One-Trick Pony Boan Biotech Files for Hong Kong IPO Into Tough Market

Key Takeaways: Boan Biotechnology sells only one product so far and is facing stiff competition from other similar drugs Luye Pharma bought Boan in 2020 and is taking it public at a time when markets are bearish By Molly Wen

The Hindu

MGU, Kannur varsity to conduct joint PG courses

In nanoscience, nanotechnology and biotechnology

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Entourage Effect In Psychedelics? Preclinical Data Identifies How Formulations Act Synergistically

Panacea Plant Sciences, a Washington State biotechnology company, has discovered formulations that act synergistically with dimethyltryptamine (DMT). The company announced the findings during the Cannabis Science Conference, on May 19.

The Hindu

Norms eased for GM crop research

The guidelines circumvent challenges of using foreign genes to change crops profile

Benzinga

AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s)

AstraZeneca plc (NASDAQ:AZN) moved to bolster its COVID-19 portfolio of antibodies with a $157 million licensing deal for experimental therapies developed by newly-launched UK-based biotech, RQ Biotechnology Ltd. In addition to the initial sum, AstraZeneca will pay possible royalty payments as part of the exclusive license to develop pre-clinical COVID antibodies engineered by RQ…

Benzinga

HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty

Given the uncertainty, HC Wainwright moderated its COVID-19 franchise estimates, the primary driver of estimate reductions, and price target reduction to $125 (from $200) on Vir Biotechnology Inc (NASDAQ:VIR). The analyst maintained a Buy rating on VIR shares. The analyst continues to view Vir's platform, validated with successful antiviral therapies against Ebola and COVID-19, and pipeline,…

Benzinga

Recap: PDS Biotechnology Q1 Earnings

PDS Biotechnology (NASDAQ:PDSB) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More

Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ: IBB), considered a proxy for the sector, shed close to 3 percent during the week.

ABC News

Biotechnology brains flock to regional Australia, but trials still based in metro areas

Much of Australia's biotech sector is based in regional Australia, but a lack of adequate, but a lack of adequate infrastructure means country patients are still missing out on the early stages of groundbreaking trials.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

European Medicines Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.